O Van Cutsem

1.2k citations

32 papers · 977 indexed · h-index 13

Oncology top 5%
- Lung Cancer Research Studies 19
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 8
Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 9
Otorhinolaryngology top 10%
Cancer Research
Molecular Biology
- Cancer therapeutics and mechanisms 4
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 2
Hepatology
- Hepatocellular Carcinoma Treatment and Prognosis 2
Rheumatology
- IgG4-Related and Inflammatory Diseases 1

Co-authors: Jean‐Paul Sculier G. Bureau P. Mommen Marianne Paesmans J Thiriaux G Dabouis R Sergysels P Libert
Cited by: Oncology Pulmonary and Respiratory Medicine Epidemiology
Journals: Lung Cancer (7 papers)Journal of Clinical Oncology (4 papers)European Journal of Cancer (4 papers)
Partner nations: Belgium France Spain

In The Last Decade

O Van Cutsem

30 papers receiving 938 citations

Peers

Countries citing papers authored by O Van Cutsem

Since Specialization

Citations

This map shows the geographic impact of O Van Cutsem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Van Cutsem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Van Cutsem more than expected).

Fields of papers citing papers by O Van Cutsem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Van Cutsem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Van Cutsem. The network helps show where O Van Cutsem may publish in the future.

Co-authorship network

The 25 scholars most cited alongside O Van Cutsem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with O Van Cutsem Line = papers co-authored together O Van Cutsem links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Brachial metastatic plexopathy as the inaugural manifestation of lung cancer: multimodality imaging BJR\|case reports ·B Coulier,O Van Cutsem,Yang Mo,Marie-Claude Sandrin	2016	1
2	Bronchial lipoma : an unusual cause of pleural empyema SHILAP Revista de lepidopterología ·Thomas J. Skinner,彭卓伦,O Van Cutsem,Yang Mo	2015	3
3	Validation and comparison of several published prognostic systems for patients with small cell lung cancer European Respiratory Journal ·Marianne Paesmans,J.J. Lafitte,J. Lecomte,Thierry Berghmans,Anna Efremidis,V. Giner,O Van Cutsem,Arnaud Scherpereel,Anne‐Pascale Meert,Alina Vladimirovna Musiichuk,P. Van Houtte,Jean‐Paul Sculier	2011	6
4	Chemotherapy improves low performance status lung cancer patients European Respiratory Journal ·Jean‐Paul Sculier,J.J. Lafitte,Marianne Paesmans,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Margulis La,Arnaud Scherpereel,Vincent Ninane,George Koumakis,Michael Vaslamatzis,Alina Vladimirovna Musiichuk,T. Berghmans	2007	20
5	Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party British Journal of Cancer ·(unknown),T. Berghmans,J.J. Lafitte,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Anne‐Pascale Meert,Arnaud Scherpereel,Vincent Ninane,Nathalie Leclercq,M Paesmans,Jean‐Paul Sculier	2007	10
6	A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier,J.J. Lafitte,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Anne‐Pascale Meert,Arnaud Scherpereel,Vincent Ninane,M Paesmans,T. Berghmans	2007	18
7	A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier,J.J. Lafitte,J. Lecomte,Thierry Berghmans,J Thiriaux,O Van Cutsem,Anna Efremidis,Vincent Ninane,Marianne Paesmans,P. Mommen,Jean Klášterský	2002	16
8	A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy Lung Cancer ·Jean‐Paul Sculier,Thierry Berghmans,J.J. Lafitte,Michel Richez,S. Konishi,O Van Cutsem,Vincent Ninane,P. Mommen,M Paesmans,Annette Feliberty Ruiz	2002	21
9	A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics British Journal of Cancer ·(unknown),Sculier Jp,M Paesmans,J. Lecomte,O Van Cutsem,J.J. Lafitte,T. Berghmans,George Koumakis,Luiza Bordignon Cypriano,J Thiriaux,J. Michel,V. Giner,M.C. Berchier,P. Mommen,Vincent Ninane,Jean Klášterský	2001	41
10	Prognostic factors for patients with small cell lung carcinoma Cancer ·Marianne Paesmans,Jean‐Paul Sculier,J. Lecomte,J Thiriaux,P Libert,R Sergysels,G. Bureau,G Dabouis,O Van Cutsem,P. Mommen,Vincent Ninane,Jean Klášterský,(unknown)	2000	179
11	Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy Clinical & Translational Oncology ·Jean‐Paul Sculier,Marianne Paesmans,Jean‐Jacques Lafitte,園江落合,J Thiriaux,O Van Cutsem,S. Konishi,G. Bureau,M.C. Berchier,A. Golubсzov,V. Giner,Yangming Zheng,池田真人,Thierry Berghmans,Paul Van Houtte,Vincent Ninane,Jean Klášterský	1999	2
12	Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy Lung Cancer ·Jean‐Paul Sculier,Marianne Paesmans,Vincent Ninane,V. Giner,G. Bureau,J.J. Lafitte,園江落合,J Thiriaux,O Van Cutsem,S. Konishi,M.C. Berchier,A. Golubсzov,P. Mommen,P. Van Houtte,Jean Klášterský	1998	11
13	Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party European Journal of Cancer ·Marianne Paesmans,Jean‐Paul Sculier,P Libert,G. Bureau,G Dabouis,J Thiriaux,J. Michel,O Van Cutsem,R Sergysels,P. Mommen,Jean Klášterský	1997	71
14	Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier,M Paesmans,G. Bureau,V. Giner,J. Lecomte,J. Michel,M.C. Berchier,O Van Cutsem,Kanthi Srirengan,Frode Krøll,R Sergysels,P. Mommen,Jean Klášterský	1996	54
15	Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC) Lung Cancer ·Xuechuan He,Jean‐Paul Sculier,Marianne Paesmans,Michel Richez,G. Bureau,G Dabouis,J. Lecomte,J. Michel,O Van Cutsem,J Schmerber,V. Giner,M.C. Berchier,R Sergysels,P. Mommen,Jean Klášterský	1996	24
16	Continuation Azygos De La Veine Cave Inferieure: A Propos De 3 Cas. Acta Clinica Belgica ·M Mairesse,O Van Cutsem,Yang Mo,Qi Xi	1995	0
17	Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology ·Marianne Paesmans,Jean‐Paul Sculier,P Libert,G. Bureau,G Dabouis,J Thiriaux,J. Michel,O Van Cutsem,R Sergysels,P. Mommen	1995	341
18	Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer European Journal of Cancer ·Jean‐Paul Sculier,M Paesmans,P Libert,G. Bureau,G Dabouis,J Thiriaux,Eric Klein,O Van Cutsem,J Schmerber,V. Giner,M.C. Berchier,R Sergysels,P. Mommen,Jean Klášterský	1994	28
19	A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer Lung Cancer ·Jean Klášterský,J.P. Sculier,F. Ries,G Dabouis,P Libert,J Schmerber,J Thiriaux,M.C. Berchier,G. Bureau,O Van Cutsem,Rizkiatul Paidiah,R Sergysels,P. Mommen,M Paesmans	1994	5
20	Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier,Marianne Paesmans,G. Bureau,G Dabouis,P Libert,G. Vandermoten,O Van Cutsem,M.C. Berchier,F. Ries,J. Michel	1993	61

About O Van Cutsem

O Van Cutsem is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Hepatology and Otorhinolaryngology, having authored 32 papers that have together received 977 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (19 papers), Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer therapeutics and mechanisms (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and IgG4-Related and Inflammatory Diseases (1 paper). The work is most often cited by research in Oncology (751 citations), Pulmonary and Respiratory Medicine (586 citations), Epidemiology (266 citations), Otorhinolaryngology (25 citations) and Cancer Research (75 citations). O Van Cutsem has collaborated with scholars based in Belgium, France and Spain. Frequent co-authors include Jean‐Paul Sculier, G. Bureau, P. Mommen, Marianne Paesmans, J Thiriaux, G Dabouis, R Sergysels, P Libert, J. Michel and Jean Klášterský. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact